FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029892458> ?p ?o ?g. }

• W2029892458 endingPage "152" @default.
• W2029892458 startingPage "147" @default.
• W2029892458 abstract "As angiogenesis represents one of the hallmarks of cancer we investigated whether intravesically administered interferon-a (IFN-a2b) reduces neo-angiogenesis in the 'normal' urothelium adjacent to the tumor in patients with superficial bladder carcinoma after complete transurethral resection (TUR) of the tumor.In the present study 47 patients after TUR of the tumor were examined. 10 patients (group A) received no further treatment (control group); 37 patients (group B) received intravesical treatment with IFN-a2b. The instillations started within 7 days after TUR, were performed weekly for 2 months, twice a month for the next 4 months, and thereafter monthly for 6 more months. Cold cup biopsies were taken before TUR of the transitional cell carcinoma (TCC): from the tumor (T), near tumor (NT) and from normal epithelium (N). Cold cup biopsies 'near tumor', were also taken during follow-up cystoscopy (C1, C2, and C3) 2, 6, and 12 months after TUR, respectively. Angiogenesis was estimated by counting the microvessels detected with CD31 immunostaining.Significant differences of microvascular density (MVD) between patients of group A and B appear after TUR (p < 0.005, Kruskal-Wallis and Wilcoxon test). The MVD difference was maximal 6 months after TUR (C2(A)-C2(B), second cystoscopy) and measured at 12.17 microvessels/ mm(2) (26.2%).Our results show that the intravesical administration of IFN-a2b after TUR significantly decreases the angiogenic potential of the 'healthy' urothelium adjacent to the tumor in patients with TCC. This observation could possibly explain, to a certain extent, the mechanism by which IFN-a2b reduces the recurrence rate of primary TCC." @default.
• W2029892458 created "2016-06-24" @default.
• W2029892458 creator A5000101129 @default.
• W2029892458 creator A5016122708 @default.
• W2029892458 creator A5020765581 @default.
• W2029892458 creator A5033587742 @default.
• W2029892458 creator A5033958914 @default.
• W2029892458 creator A5038121652 @default.
• W2029892458 creator A5043223752 @default.
• W2029892458 creator A5045356211 @default.
• W2029892458 creator A5052690472 @default.
• W2029892458 creator A5071628916 @default.
• W2029892458 creator A5076145446 @default.
• W2029892458 date "2003-01-01" @default.
• W2029892458 modified "2023-09-27" @default.
• W2029892458 title "Interferon-a2b Reduces Neo-Microvascular Density in the ‘Normal’ Urothelium Adjacent to the Tumor after Transurethral Resection of Superficial Bladder Carcinoma" @default.
• W2029892458 cites W1503840679 @default.
• W2029892458 cites W1530231068 @default.
• W2029892458 cites W1582867567 @default.
• W2029892458 cites W1816491638 @default.
• W2029892458 cites W1857696541 @default.
• W2029892458 cites W1968098021 @default.
• W2029892458 cites W1971593005 @default.
• W2029892458 cites W1972528954 @default.
• W2029892458 cites W1972890481 @default.
• W2029892458 cites W1981541848 @default.
• W2029892458 cites W1985804036 @default.
• W2029892458 cites W1994360534 @default.
• W2029892458 cites W1998255684 @default.
• W2029892458 cites W2003522344 @default.
• W2029892458 cites W2010476650 @default.
• W2029892458 cites W2010870294 @default.
• W2029892458 cites W2022075225 @default.
• W2029892458 cites W2040822164 @default.
• W2029892458 cites W2058331779 @default.
• W2029892458 cites W2086406008 @default.
• W2029892458 cites W2088023845 @default.
• W2029892458 cites W2092094151 @default.
• W2029892458 cites W2098234838 @default.
• W2029892458 cites W2105239075 @default.
• W2029892458 cites W2108527315 @default.
• W2029892458 cites W2134253312 @default.
• W2029892458 cites W2141854356 @default.
• W2029892458 cites W2158743409 @default.
• W2029892458 cites W2285543173 @default.
• W2029892458 cites W2340893063 @default.
• W2029892458 cites W2396725961 @default.
• W2029892458 cites W2402487223 @default.
• W2029892458 cites W2407256160 @default.
• W2029892458 cites W2425308505 @default.
• W2029892458 cites W7317053 @default.
• W2029892458 doi "https://doi.org/10.1159/000069835" @default.
• W2029892458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12771523" @default.
• W2029892458 hasPublicationYear "2003" @default.
• W2029892458 type Work @default.
• W2029892458 sameAs 2029892458 @default.
• W2029892458 citedByCount "7" @default.
• W2029892458 countsByYear W20298924582012 @default.
• W2029892458 countsByYear W20298924582013 @default.
• W2029892458 crossrefType "journal-article" @default.
• W2029892458 hasAuthorship W2029892458A5000101129 @default.
• W2029892458 hasAuthorship W2029892458A5016122708 @default.
• W2029892458 hasAuthorship W2029892458A5020765581 @default.
• W2029892458 hasAuthorship W2029892458A5033587742 @default.
• W2029892458 hasAuthorship W2029892458A5033958914 @default.
• W2029892458 hasAuthorship W2029892458A5038121652 @default.
• W2029892458 hasAuthorship W2029892458A5043223752 @default.
• W2029892458 hasAuthorship W2029892458A5045356211 @default.
• W2029892458 hasAuthorship W2029892458A5052690472 @default.
• W2029892458 hasAuthorship W2029892458A5071628916 @default.
• W2029892458 hasAuthorship W2029892458A5076145446 @default.
• W2029892458 hasConcept C121608353 @default.
• W2029892458 hasConcept C126322002 @default.
• W2029892458 hasConcept C126894567 @default.
• W2029892458 hasConcept C141071460 @default.
• W2029892458 hasConcept C142724271 @default.
• W2029892458 hasConcept C2777540882 @default.
• W2029892458 hasConcept C2777546739 @default.
• W2029892458 hasConcept C2778065480 @default.
• W2029892458 hasConcept C2778769751 @default.
• W2029892458 hasConcept C2778939058 @default.
• W2029892458 hasConcept C2779762690 @default.
• W2029892458 hasConcept C2780017030 @default.
• W2029892458 hasConcept C2780352672 @default.
• W2029892458 hasConcept C2780394083 @default.
• W2029892458 hasConcept C71924100 @default.
• W2029892458 hasConcept C77411442 @default.
• W2029892458 hasConceptScore W2029892458C121608353 @default.
• W2029892458 hasConceptScore W2029892458C126322002 @default.
• W2029892458 hasConceptScore W2029892458C126894567 @default.
• W2029892458 hasConceptScore W2029892458C141071460 @default.
• W2029892458 hasConceptScore W2029892458C142724271 @default.
• W2029892458 hasConceptScore W2029892458C2777540882 @default.
• W2029892458 hasConceptScore W2029892458C2777546739 @default.
• W2029892458 hasConceptScore W2029892458C2778065480 @default.
• W2029892458 hasConceptScore W2029892458C2778769751 @default.
• W2029892458 hasConceptScore W2029892458C2778939058 @default.
• W2029892458 hasConceptScore W2029892458C2779762690 @default.

• next